| Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA,IDH1,EGFR, and NF1 RGW Verhaak, KA Hoadley, E Purdom, V Wang, Y Qi, MD Wilkerson, ... Cancer cell 17 (1), 98-110, 2010 | 8157 | 2010 |
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways R McLendon, A Friedman, D Bigner, EG Van Meir, DJ Brat, ... Nature 455 (7216), 1061-1068, 2008 | 7506 | 2008 |
| The landscape of somatic copy-number alteration across human cancers R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ... Nature 463 (7283), 899-905, 2010 | 4422 | 2010 |
| Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 DA Barbie, P Tamayo, JS Boehm, SY Kim, SE Moody, IF Dunn, ... Nature 462 (7269), 108-112, 2009 | 3330 | 2009 |
| Somatic mutations affect key pathways in lung adenocarcinoma L Ding, G Getz, DA Wheeler, ER Mardis, MD McLellan, K Cibulskis, ... Nature 455 (7216), 1069-1075, 2008 | 3146 | 2008 |
| Next-generation characterization of the Cancer Cell Line Encyclopedia M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ... Nature 569 (7757), 503, 2019 | 2727 | 2019 |
| Defining a cancer dependency map A Tsherniak, F Vazquez, PG Montgomery, BA Weir, G Kryukov, ... Cell 170 (3), 564-576. e16, 2017 | 2346 | 2017 |
| Absolute quantification of somatic DNA alterations in human cancer SL Carter, K Cibulskis, E Helman, A McKenna, H Shen, T Zack, PW Laird, ... Nature biotechnology 30 (5), 413, 2012 | 2068 | 2012 |
| Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells RM Meyers, JG Bryan, JM McFarland, BA Weir, AE Sizemore, H Xu, ... Nature genetics 49 (12), 1779, 2017 | 1692 | 2017 |
| Characterizing the cancer genome in lung adenocarcinoma BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ... Nature 450 (7171), 893-898, 2007 | 1296 | 2007 |
| Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study K Shedden, JMG Taylor, SA Enkemann, MS Tsao, TJ Yeatman, ... Nature medicine 14 (8), 822-827, 2008 | 1141 | 2008 |
| SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas AJ Bass, H Watanabe, CH Mermel, S Yu, S Perner, RG Verhaak, SY Kim, ... Nature genetics 41 (11), 1238, 2009 | 1088 | 2009 |
| β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis J Rosenbluh, D Nijhawan, AG Cox, X Li, JT Neal, EJ Schafer, TI Zack, ... Cell 151 (7), 1457-1473, 2012 | 845 | 2012 |
| Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy J Barretina, BS Taylor, S Banerji, AH Ramos, M Lagos-Quintana, ... Nature genetics 42 (8), 715, 2010 | 808 | 2010 |
| Genomic copy number dictates a gene-independent cell response to CRISPR/Cas9 targeting AJ Aguirre, RM Meyers, BA Weir, F Vazquez, CZ Zhang, U Ben-David, ... Cancer discovery 6 (8), 914-929, 2016 | 674 | 2016 |
| PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR ML Sos, M Koker, BA Weir, S Heynck, R Rabinovsky, T Zander, ... Cancer research 69 (8), 3256-3261, 2009 | 662 | 2009 |
| Highly parallel identification of essential genes in cancer cells B Luo, HW Cheung, A Subramanian, T Sharifnia, M Okamoto, X Yang, ... Proceedings of the National Academy of Sciences 105 (51), 20380-20385, 2008 | 651 | 2008 |
| Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway CA Lovejoy, W Li, S Reisenweber, S Thongthip, J Bruno, T De Lange, ... PLoS genetics 8 (7), e1002772, 2012 | 637 | 2012 |
| Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer HW Cheung, GS Cowley, BA Weir, JS Boehm, S Rusin, JA Scott, A East, ... Proceedings of the National Academy of Sciences 108 (30), 12372-12377, 2011 | 519 | 2011 |
| MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells GV Kryukov, FH Wilson, JR Ruth, J Paulk, A Tsherniak, SE Marlow, ... Science 351 (6278), 1214-1218, 2016 | 513 | 2016 |
